DMM and COVID-19

We are aware that the COVID-19 pandemic is having an unprecedented impact on researchers worldwide. The Editors of all The Company of Biologists’ journals have been considering ways in which we can alleviate concerns that members of our community may have around publishing activities during this time. Read about the actions we are taking at this time.

Please don’t hesitate to contact the Editorial Office if you have any questions or concerns.

Find DMM online

We may not be meeting you in person this year, but we’re always here to chat about DMM and The Company of Biologists. Join the conversation over on Twitter, email us or catch Scientific Editor Julija Hmeljak at these upcoming virtual meetings:

MRC Human Genetics Unit (Virtual) Symposium: Aberrant Cell State Transitions in Human Disease
23-24 September

Genomic Imprinting – from Biology to Disease
28 September – 1 October

ZDMS Virtual webinar series
Throughout September – December

Editor’s choice - A mouse SWATH-mass spectrometry reference spectral library enables deconvolution of species-specific proteomic alterations in human tumour xenografts

A Resource article from Paul Huang’s lab presents a comprehensive SWATH-MS reference library of over 10,000 mouse proteins from seven organs and eight murine cell lines, available for use by the proteomics community.

Interview – Jenny Vermeer and Jonathan Ient

A new paper in DMM highlights a lineage-tracing tool to map the fate of hypoxic tumour cells. First authors Jenny Vermeer and Jonathan Ient take us behind the scenes of their research, in an interview.

Temporal patterning in neural progenitors: from Drosophila development to childhood cancers

In a Review, Cédric Maurange draws on new concepts from Drosophila research to understand the links between development and paediatric CNS cancers.